REG - Hikma Pharmaceutical - Block listing Interim Review <Origin Href="QuoteRef">HIK.L</Origin>
RNS Number : 8014SHikma Pharmaceuticals Plc05 October 2017Block Listing Six Monthly Return
Information provided on this form must be typed or printed electronically and provided to an RIS.
Date: 5 October 2017
Name of applicant:
Hikma Pharmaceuticals PLC
Name of scheme:
Hikma Pharmaceuticals PLC 2004 Stock Option Plan ("SOP")
&
Hikma Pharmaceuticals PLC 2005 Long-Term Incentive Plan ("LTIP")
&
Hikma Pharmaceuticals PLC 2009 Management Incentive Plan ("MIP")
&
Hikma Pharmaceuticals PLC 2014 Executive Incentive Plan ("EIP")
Period of return
From:
1 April 2017
To:
30 September 2017
Balance of unallotted securities under scheme(s) from previous return:
SOP: 792,700 ordinary shares of 10 pence
LTIP: 390,091 ordinary shares of 10 pence
MIP: 310,614 ordinary shares of 10 pence
EIP: 364,606 ordinary shares of 10 pence
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
SOP: 0 ordinary shares of 10 pence
LTIP: 0 ordinary shares of 10 pence
MIP: 0 ordinary shares of 10 pence
EIP: 0 ordinary shares of 10 pence
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
SOP: 0 ordinary shares of 10 pence
LTIP: 264,814 ordinary shares of 10 pence
MIP: 123,153 ordinary shares of 10 pence
EIP: 284,562 ordinary shares of 10 pence
Equals: Balance under scheme(s) not yet issued/allotted at end of period:
SOP: 792,700 ordinary shares of 10 pence
LTIP: 125,277 ordinary shares of 10 pence
MIP: 187,461 ordinary shares of 10 pence
EIP: 80,044 ordinary shares of 10 pence
Name of contact:
Peter Speirs
Telephone number of contact:
0207 399 2772
Stock Option Plan ("SOP")
Date
Block Listing
Shares Issued
Balance (Headroom)
Notes
01/04/2017
-
-
792,700
Blocklisting return on 01/04/17
01/10/2017
-
-
792,700
Blocklisting return on 01/10/17
Long Term Incentive Plan ("LTIP")
Date
Block Listing
Shares Issued
Balance (Headroom)
Notes
01/04/2017
-
-
390,091
Blocklisting return on 01/04/17
06/04/2017
0
8,000
382,091
11/04/2017
0
65,995
316,096
30/05/2017
0
90,252
225,844
11/06/2017
0
96,220
129,624
18/06/2017
0
4,347
125,277
01/10/2017
-
-
125,277
Blocklisting return on 01/10/17
Management Incentive Plan ("MIP")
Date
Block Listing
Shares Issued
Balance (Headroom)
Notes
01/04/2017
-
-
310,614
Blocklisting return on 01/04/17
17/05/2017
0
117,709
192,905
21/06/2017
0
1,340
191,565
08/08/2017
0
4,104
187,461
01/10/2017
-
-
187,461
Blocklisting return on 01/10/17
Executive Incentive Plan ("EIP")
Date
Block Listing
Shares Issued
Balance (Headroom)
Notes
01/04/2017
-
-
364,606
Blocklisting return on 01/04/17
12/04/2017
0
213,562
151,044
17/05/2017
0
71,000
80,044
01/10/2017
-
-
80,044
Blocklisting return on 01/10/17
This information is provided by RNSThe company news service from the London Stock ExchangeENDBLRUGGGCUUPMURA
Recent news on Hikma Pharmaceuticals
See all newsREG - Hikma Pharmaceutical - Director/PDMR Shareholding
AnnouncementREG - Hikma Pharmaceutical - Transaction in Own Shares
AnnouncementREG - Hikma Pharmaceutical - Transaction in Own Shares
AnnouncementREG - Hikma Pharmaceutical - Transaction in Own Shares
AnnouncementREG - Hikma Pharmaceutical - Transaction in Own Shares
Announcement